Seeking Alpha

GlaxoSmithKline (GSK) buys 10M shares of Theravance (THRX) at a price of $21.2887 a pop - taking...

GlaxoSmithKline (GSK) buys 10M shares of Theravance (THRX) at a price of $21.2887 a pop - taking its stake in the asthma drug firm up to 26.8%. The transaction needs the approval of Theravance's stockholders before closing. Premarket: GSK +0.7%, THRX inactive.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)